The number of people who are diagnosed with diabetes around the world is approaching 400 million.
In the UK, there are 3.2 million people diagnosed with the condition and an estimated 630,000 people have it, but don’t know it. The cost of diabetes to the NHS is estimated to be about £10 billion a year overall, with £7.7 billion related to health complications and £2.1 billion spent on treatments.
This is a huge amount of money, and with the World Health Organisation (WHO) predicting a 55 per cent increase by 2035 in people living with diabetes worldwide, the cost is only going to increase and put a strain on the already limited resources.
PolyPhotonix, a bio-photonic and OLED (organic light-emitting diode) research company headed up by Richard Kirk, has developed an innovative product that can save the NHS up to £1 billion a year by preventing and treating diabetes retinopathy and age related macular degeneration.